arrow
D

David S. Stephens

Emory University School of Medicine
H指数:75
被引数:1.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Systemic and Mucosal Antibody Responses Against Neisseria gonorrhoeae (Ng) Outer Membrane Vesicle Antigens following Four-Component Meningococcal Serogroup B (4CMenB) Immunization in Healthy Adults: A Randomized Phase II Trial

健康成人接种四组分B群脑膜炎球菌疫苗(4CMenB)后针对奈瑟氏淋病奈瑟菌(Ng)外膜囊泡抗原的系统性和黏膜抗体应答:一项随机II期试验

2026-09-230
OAAI
Mucosal and Systemic Antibody Responses After Boosting With a Bivalent Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine

使用双价信使核糖核酸严重急性呼吸综合征冠状病毒2疫苗加强接种后的黏膜和系统性抗体应答

2025-04-290
PRE
The Neisseria meningitidis Urethritis Clade (NmUC) Acts as a Chimeric Pathogen During Infection of Primary, Human Male, Urethral Epithelial Cells

脑膜炎奈瑟氏球菌尿道炎进化枝 (NmUC) 在感染原发性人类男性尿道上皮细胞期间充当嵌合病原体

2024-12-050
PRE
Ultrastructural, metabolic and genetic characteristics of determinants facilitating the acquisition of macrolide resistance by Streptococcus pneumoniae

促进肺炎链球菌获得大环内酯类耐药性的决定因素的超微结构,代谢和遗传特征

2024-11-010
OAAI
Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial
2023-08-2819
OAAI
Immunogenicity of NVX-CoV2373 heterologous boost against SARS-CoV-2 variants
2023-07-1117
OAAI
Meningococcal disease in North America: Updates from the Global Meningococcal Initiative

北美的脑膜炎球菌病: 全球脑膜炎球菌倡议的更新

2022-12-019
PRE
Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant
2022-07-01126
OAAI
Homologous and Heterologous Covid-19 Booster Vaccinations
2022-03-17399
OAAI